35 results
8-K
EX-99.2
LBPH
Longboard Pharmaceuticals, Inc.
1 Aug 24
Longboard Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
4:10pm
disclosed in our filings with the U.S. Securities and Exchange Commission (the “SEC”). We operate in a very competitive and rapidly changing environment
8-K
EX-99.2
LBPH
Longboard Pharmaceuticals, Inc.
10 Jun 24
Regulation FD Disclosure
9:05am
Quarterly Reports on Form 10-Q, and in our other filings. We operate in a very competitive and rapidly changing environment. New risks emerge from time
PRE 14A
r8k63
28 Mar 24
Preliminary proxy
4:36pm
8-K
EX-99.2
gwi4vqzpl8o ua
12 Mar 24
Longboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate Updates
4:10pm
8-K
EX-1.1
w6wjou6
4 Jan 24
Other Events
4:51pm
424B5
2xe2vm6 0yjrxljqq87
4 Jan 24
Prospectus supplement for primary offering
4:48pm
424B5
f4q0 umrzq9v
2 Jan 24
Prospectus supplement for primary offering
4:54pm
8-K
EX-99.2
hgvjm 258
2 Jan 24
Regulation FD Disclosure
9:44am
8-K
EX-99.1
hs4bmubds
29 Nov 23
Regulation FD Disclosure
8:35am
8-K
EX-99.1
581sctpz42leifcp7lep
11 Oct 23
Regulation FD Disclosure
9:26am
8-K
EX-99.1
or3u0glwrmrip3
5 Dec 22
Regulation FD Disclosure
8:45am
S-3
EX-1.2
mpmcdfuzp
30 Sep 22
Shelf registration
4:11pm